ArticleBreast cancer research and treatment2020

Trend and survival benefit of Oncotype DX use among female hormone receptor-positive breast cancer patients in 17 SEER registries, 2004-2015.

Lu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.